Rivaroxaban reduces risk of venous thromboembolismTreatment with the oral factor Xa inhibitor rivaroxaban reduces the risk of recurrent venous thromboembolism—and it does so without an increase in bleeding, researchers said here. Resistant infections on rise among middle-age adultsU.S. hospital-based study documents two-decade drop in mean age since 1997 Apixaban prevents clots after knee, hip surgery New anticoagulant taken orally has advantage over standard therapy that is injected subcutaneously daily Handheld computers improve patient care Doctors using personal digital assistants report finding valuable information New Canadian Physical Activity Guidelines Children need at least 60 minutes of physical activity daily, adults 150 minutes weekly. Renal denervation shows promise in refractory hypertension Catheter ablation of sympathetic nerves produces significant blood pressure reductions Abdominal massage eases constipation in MS patients Success of small feasibility study could lead to full multicentre trial Omega-3s fail to fix atrial fibrillation Notorious autism paper a fraud, journal declares Report confirms disproportionate toll of drug abuse First Previous 364 365 366 367 368 Next Last
